Expert Panel Consensus on State-Level Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder.

Rosanna Smart, Sean Grant, Adam J Gordon, Rosalie Liccardo Pacula, Bradley D Stein
Author Information
  1. Rosanna Smart: Economics, Sociology, and Statistics Department, RAND Corporation, Santa Monica, California.
  2. Sean Grant: Department of Social & Behavioral Sciences, Indiana University Richard M. Fairbanks School of Public Health, Indianapolis.
  3. Adam J Gordon: Program for Addiction Research, Clinical Care, Knowledge and Advocacy, Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City.
  4. Rosalie Liccardo Pacula: Sol Price School of Public Policy and Leonard D. Schaeffer Center for Health Policy & Economics, University of Southern California, Los Angeles.
  5. Bradley D Stein: Behavioral and Policy Sciences Department, RAND Corporation, Pittsburgh, Pennsylvania.

Abstract

Importance: In the US, recent legislation and regulations have been considered, proposed, and implemented to improve the quality of treatment for opioid use disorder (OUD). However, insufficient empirical evidence exists to identify which policies are feasible to implement and successfully improve patient and population-level outcomes.
Objective: To examine expert consensus on the effectiveness and the ability to implement state-level OUD treatment policies.
Evidence Review: This qualitative study used the ExpertLens online platform to conduct a 3-round modified Delphi process to convene 66 stakeholders (health care clinicians, social service practitioners, addiction researchers, health policy decision-makers, policy advocates, and persons with lived experience). Stakeholders participated in 1 of 2 expert panels on 14 hypothetical state-level policies targeting treatment engagement and linkage, evidence-based and integrated care, treatment flexibility, and monitoring or support services. Participants rated policies in round 1, discussed results in round 2, and provided final ratings in round 3. Participants used 4 criteria associated with either the effectiveness or implementability to rate and discuss each policy. The effectiveness panel (n = 29) considered policy effects on treatment engagement, treatment retention, OUD remission, and opioid overdose mortality. The implementation panel (n = 34) considered the acceptability, feasibility, affordability, and equitability of each policy. We measured consensus using the interpercentile range adjusted for symmetry analysis technique from the RAND/UCLA appropriateness method.
Findings: Both panels reached consensus on all items. Experts viewed 2 policies (facilitated access to medications for OUD and automatic Medicaid enrollment for citizens returning from correctional settings) as highly implementable and highly effective in improving patient and population-level outcomes. Participants rated hub-and-spoke-type policies and provision of financial incentives to emergency departments for treatment linkage as effective; however, they also rated these policies as facing implementation barriers associated with feasibility and affordability. Coercive policies and policies levying additional requirements on individuals with OUD receiving treatment (eg, drug toxicology testing, counseling requirements) were viewed as low-value policies (ie, decreasing treatment engagement and retention, increasing overdose mortality, and increasing health inequities).
Conclusions and Relevance: The findings of this study may provide urgently needed consensus on policies for states to consider either adopting or deimplementing in their efforts to address the opioid overdose crisis.

References

  1. Implement Sci. 2022 Jan 6;17(1):3 [PMID: 34991638]
  2. Health Aff (Millwood). 2015 Jun;34(6):1028-34 [PMID: 26056209]
  3. Int J Drug Policy. 2021 Dec;98:103383 [PMID: 34340167]
  4. J Addict Med. 2022 Mar-Apr 01;16(2):192-207 [PMID: 34014209]
  5. JAMA Netw Open. 2018 Sep 7;1(5):e182943 [PMID: 30646185]
  6. Health Aff (Millwood). 2015 Dec;34(12):2044-51 [PMID: 26643624]
  7. J Health Econ. 2021 Jan;75:102408 [PMID: 33316762]
  8. Milbank Q. 2020 Mar;98(1):57-105 [PMID: 31800142]
  9. BMJ. 2017 Apr 26;357:j1550 [PMID: 28446428]
  10. Health Aff (Millwood). 2019 Dec;38(12):2105-2108 [PMID: 31794297]
  11. Psychiatr Serv. 2012 Jan;63(1):19-25 [PMID: 22227755]
  12. JAMA Netw Open. 2022 Feb 1;5(2):e2148599 [PMID: 35166780]
  13. Am J Prev Med. 2014 Jan;46(1):10-6 [PMID: 24355666]
  14. N Engl J Med. 2022 Apr 21;386(16):1488-1490 [PMID: 35081297]
  15. Ann Intern Med. 2017 Feb 21;166(4):268-278 [PMID: 27919103]
  16. Drug Alcohol Depend. 2019 Nov 1;204:107563 [PMID: 31585357]
  17. JAMA Health Forum. 2021 Nov;2(11):e213833 [PMID: 35647581]
  18. BMC Med Res Methodol. 2011 Dec 23;11:174 [PMID: 22196011]
  19. BMJ. 2016 Jun 28;353:i2016 [PMID: 27353417]
  20. Psychiatr Serv. 2021 Sep 1;72(9):1048-1056 [PMID: 33593105]
  21. J Addict Med. 2017 May/Jun;11(3):163-173 [PMID: 28557958]
  22. Health Aff (Millwood). 2016 Dec 1;35(12):2289-2296 [PMID: 27920318]
  23. JAMA Netw Open. 2020 Feb 5;3(2):e1920622 [PMID: 32022884]
  24. Health Technol Assess. 1998;2(3):i-iv, 1-88 [PMID: 9561895]
  25. PLoS Med. 2019 Dec 31;16(12):e1003002 [PMID: 31891578]
  26. N Engl J Med. 2018 Jul 5;379(1):4-6 [PMID: 29972745]
  27. Cochrane Database Syst Rev. 2009 Jul 08;(3):CD002209 [PMID: 19588333]
  28. JAMA Psychiatry. 2019 Sep 1;76(9):979-981 [PMID: 31066881]
  29. Prev Med Rep. 2019 Nov 06;17:101015 [PMID: 31993300]
  30. Subst Abus. 2021;42(4):716-725 [PMID: 33284083]
  31. Am J Psychiatry. 2017 Aug 1;174(8):738-747 [PMID: 27978771]
  32. J Pediatr. 2022 Apr;243:33-39.e1 [PMID: 34942181]
  33. JAMA Oncol. 2022 Aug 1;8(8):1107-1114 [PMID: 35771550]
  34. Health Res Policy Syst. 2018 May 29;16(1):45 [PMID: 29843743]
  35. Am Econ J Econ Policy. 2018 Nov;10(4):1-35 [PMID: 34326924]
  36. Cochrane Database Syst Rev. 2014 Feb 06;(2):CD002207 [PMID: 24500948]
  37. J Subst Abuse Treat. 2018 Aug;91:57-68 [PMID: 29910015]
  38. J Addict Med. 2017 Jul/Aug;11(4):286-292 [PMID: 28379862]
  39. J Clin Epidemiol. 2021 Mar;131:133-140 [PMID: 33276054]
  40. JAMA Netw Open. 2021 Dec 1;4(12):e2139968 [PMID: 34962565]
  41. Subst Abuse. 2021 Aug 30;15:11782218211039781 [PMID: 34483660]
  42. Acad Med. 2014 Sep;89(9):1245-51 [PMID: 24979285]
  43. J Subst Abuse Treat. 2020 Jan;108:20-25 [PMID: 31399272]

Grants

  1. P50 DA046351/NIDA NIH HHS
  2. R01 DA045800/NIDA NIH HHS

MeSH Term

Consensus
Drug Overdose
Health Policy
Humans
Opiate Overdose
Opiate Substitution Treatment
Opioid-Related Disorders
United States

Word Cloud

Created with Highcharts 10.0.0policiestreatmentOUDpolicyconsensusconsideredopioideffectivenesshealth2engagementParticipantsratedroundoverdoseimproveimplementpatientpopulation-leveloutcomesexpertstate-levelstudyusedcare1panelslinkageassociatedeitherpanelretentionmortalityimplementationfeasibilityaffordabilityviewedhighlyeffectiverequirementsincreasingImportance:USrecentlegislationregulationsproposedimplementedqualityusedisorderHoweverinsufficientempiricalevidenceexistsidentifyfeasiblesuccessfullyObjective:examineabilityEvidenceReview:qualitativeExpertLensonlineplatformconduct3-roundmodifiedDelphiprocessconvene66stakeholdersclinicianssocialservicepractitionersaddictionresearchersdecision-makersadvocatespersonslivedexperienceStakeholdersparticipated14hypotheticaltargetingevidence-basedintegratedflexibilitymonitoringsupportservicesdiscussedresultsprovidedfinalratings34criteriaimplementabilityratediscussn = 29effectsremissionn = 34acceptabilityequitabilitymeasuredusinginterpercentilerangeadjustedsymmetryanalysistechniqueRAND/UCLAappropriatenessmethodFindings:reacheditemsExpertsfacilitatedaccessmedicationsautomaticMedicaidenrollmentcitizensreturningcorrectionalsettingsimplementableimprovinghub-and-spoke-typeprovisionfinancialincentivesemergencydepartmentshoweveralsofacingbarriersCoercivelevyingadditionalindividualsreceivingegdrugtoxicologytestingcounselinglow-valueiedecreasinginequitiesConclusionsRelevance:findingsmayprovideurgentlyneededstatesconsideradoptingdeimplementingeffortsaddresscrisisExpertPanelConsensusState-LevelPoliciesImproveEngagementRetentionTreatmentOpioidUseDisorder

Similar Articles

Cited By